Filing Flows

Filing Flows › Companies › AbbVie › Timeline

AbbVie stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions+37.0% to $291.31

AbbVie (ABBV) stock rose 37% over the last 252 sessions, to $291.31. On the way it reported 4 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside) and 1 Form 144 notice of planned sales, and the company filed 2 material 8-Ks. Each is marked on the price and listed with what the stock did next.

ABBV: a year of the stock with every disclosure on itABBV: a year of the stock with every disclosure on it$216$245$274$303●2026-02-04 · Earnings: beat the EPS estimate by 2.2%●2026-04-29 · Earnings: missed the EPS estimate by -0.8%●2026-07-31 · Earnings: beat the EPS estimate by 1.2%▽2026-08-14 · Form 144: Nicholas Donoghoe plans to sell $8.2M◆2026-10-15 · Directors and officers: departures, appointments, pay●2026-10-30 · Earnings: beat the EPS estimate by 1.5%◆2026-11-02 · Directors and officers: departures, appointments, pay●Earnings report▽Planned sale (Form 144)◆8-K event2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Nov 2, 20268-KDirectors and officers: departures, appointments, pay−1.0% (−1.3% vs SPY)——
Oct 30, 2026EarningsEarnings: beat the EPS estimate by 1.5%+1.4% (+3.2% vs SPY)−0.9% (+4.0% vs SPY)—
Oct 15, 20268-KDirectors and officers: departures, appointments, pay+0.7% (+1.8% vs SPY)+0.6% (+1.7% vs SPY)—
Aug 14, 2026Form 144Form 144: Nicholas Donoghoe plans to sell $8.2M−0.5% (−0.3% vs SPY)+4.3% (+6.3% vs SPY)+4.3% (+6.5% vs SPY)
Jul 31, 2026EarningsEarnings: beat the EPS estimate by 1.2%−2.6% (−3.3% vs SPY)−5.4% (−9.0% vs SPY)−0.8% (−4.4% vs SPY)
Apr 29, 2026EarningsEarnings: missed the EPS estimate by -0.8%+3.1% (+3.1% vs SPY)+4.2% (+2.5% vs SPY)+10.1% (+4.2% vs SPY)
Feb 4, 2026EarningsEarnings: beat the EPS estimate by 2.2%−3.9% (−3.4% vs SPY)−1.4% (−1.8% vs SPY)+2.9% (+4.1% vs SPY)

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → AbbVie: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.